[For Immediate Release]

Union Medical Healthcare wins award "Excellence in Innovation in Medical Aesthetic Market (Asia Pacific)" from Frost & Sullivan for professionalism and innovative spirit
Consolidates the Group's leading position in the industry

(25 September, 2017) Union Medical Healthcare Limited ("Union Medical Healthcare" or the "Company", which together with its subsidiaries, is referred to as the "Group", SEHK stock code: 2138), the leading aesthetic medical service provider in Hong Kong, is pleased to announce that the Group has received an award, the "Excellence in Innovation in Medical Aesthetic Market (Asia Pacific)" from the renowned global consulting firm Frost & Sullivan in "Growth, Innovation and Leadership Best Practice Award Ceremony for Listed Company 2017". The accolade was presented to the Group in recognition of its consistent innovation endeavours that promote the professionalism of the industry.

"Growth, Innovation and Leadership Best Practice Award for Listed Company" is aimed at celebrating companies which have exemplary achievements in leadership, innovation, client servicing and product development. A Frost & Sullivan team judged the competition and decided on the winners who were outstanding brands.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of Union Medical Healthcare said, "It is a great honour to have been awarded the 'Excellence in Innovation in Medical Aesthetic Market (Asia Pacific)'. The award represents recognition of the Group's outstanding performance by a professional organization and the market. Looking ahead, the Group will continue to exert influence as an industry leader by introducing more innovative and safe products and services into the market. Such initiative will help to consolidate the Group's leading position in the market for aesthetic medical services and further promote Hong Kong as a hub of medical aesthetics in Asia Pacific."

-End-
 

About Union Medical Healthcare Limited
Union Medical Healthcare is principally engaged in the provision of one-stop aesthetic medical, beauty and health management solutions with 38 clinics and servicing centres across Hong Kong, the PRC and Macao as at 31 May 2017. In 2016, the Group obtained the Hong Kong Top Service Brand and opened re:HEALTH, a one-stop health management centre, to provide a full range of services and products, including comprehensive health screening, health product and health management services. The Group is the largest aesthetic medical service provider in Hong Kong in terms of revenue. The Group ranked first in Hong Kong from 2012 to 2016 in terms of the number of aesthetic injection procedures performed involving utilization of the top-six revenue-generating aesthetic medications in Hong Kong; and was the Black Diamond Provider of the transparent orthodontic device for teeth alignment, Invisalign(R), in 2015 and 2016. The Group has successfully built DR REBORN, a well-recognized brand in Hong Kong, with the reputation of being a premier provider of aesthetic medical services in Hong Kong.

For further information, please contact:
iPR Ogilvy & Mather
Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639
Fax: (852) 3170 6606
Email: umh@iprogilvy.com